These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 27033509)

  • 1. Lipid-based siRNA Delivery Systems: Challenges, Promises and Solutions Along the Long Journey.
    Sarisozen C; Salzano G; Torchilin VP
    Curr Pharm Biotechnol; 2016; 17(8):728-40. PubMed ID: 27033509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifunctional pH-Sensitive Amino Lipids for siRNA Delivery.
    Gujrati M; Vaidya A; Lu ZR
    Bioconjug Chem; 2016 Jan; 27(1):19-35. PubMed ID: 26629982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
    Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN
    Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid and Polymer-Based Nanoparticle siRNA Delivery Systems for Cancer Therapy.
    Mainini F; Eccles MR
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32532030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of an efficient short interference RNA (siRNA) delivery system with a new pH-sensitive cationic lipid].
    Sato Y; Hatakeyama H; Hyodo M; Akita H; Harashima H
    Yakugaku Zasshi; 2012; 132(12):1355-63. PubMed ID: 23208041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid-based systemic delivery of siRNA.
    Tseng YC; Mozumdar S; Huang L
    Adv Drug Deliv Rev; 2009 Jul; 61(9):721-31. PubMed ID: 19328215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technologies for investigating the physiological barriers to efficient lipid nanoparticle-siRNA delivery.
    Shi B; Abrams M
    J Histochem Cytochem; 2013 Jun; 61(6):407-20. PubMed ID: 23504369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid nanoparticles for short interfering RNA delivery.
    Leung AK; Tam YY; Cullis PR
    Adv Genet; 2014; 88():71-110. PubMed ID: 25409604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing endosomal escape for nanoparticle mediated siRNA delivery.
    Ma D
    Nanoscale; 2014 Jun; 6(12):6415-25. PubMed ID: 24837409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimuli-responsive hybrid nanocarriers developed by controllable integration of hyperbranched PEI with mesoporous silica nanoparticles for sustained intracellular siRNA delivery.
    Prabhakar N; Zhang J; Desai D; Casals E; Gulin-Sarfraz T; Näreoja T; Westermarck J; Rosenholm JM
    Int J Nanomedicine; 2016; 11():6591-6608. PubMed ID: 27994460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid-based nanoparticles in the systemic delivery of siRNA.
    Lin Q; Chen J; Zhang Z; Zheng G
    Nanomedicine (Lond); 2014 Jan; 9(1):105-20. PubMed ID: 24354813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid-Based Liquid Crystalline Nanoparticles Facilitate Cytosolic Delivery of siRNA via Structural Transformation.
    He S; Fan W; Wu N; Zhu J; Miao Y; Miao X; Li F; Zhang X; Gan Y
    Nano Lett; 2018 Apr; 18(4):2411-2419. PubMed ID: 29561622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent developments in nanoparticle-based siRNA delivery for cancer therapy.
    Lee JM; Yoon TJ; Cho YS
    Biomed Res Int; 2013; 2013():782041. PubMed ID: 23844368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cuboplexes: Topologically Active siRNA Delivery.
    Kim H; Leal C
    ACS Nano; 2015 Oct; 9(10):10214-26. PubMed ID: 26390340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifunctional cationic lipid-based nanoparticles facilitate endosomal escape and reduction-triggered cytosolic siRNA release.
    Gujrati M; Malamas A; Shin T; Jin E; Sun Y; Lu ZR
    Mol Pharm; 2014 Aug; 11(8):2734-44. PubMed ID: 25020033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of physiological and biochemical barriers to siRNA liver delivery via lipid nanoparticle platform.
    Xu Y; Ou M; Keough E; Roberts J; Koeplinger K; Lyman M; Fauty S; Carlini E; Stern M; Zhang R; Yeh S; Mahan E; Wang Y; Slaughter D; Gindy M; Raab C; Thompson C; Hochman J
    Mol Pharm; 2014 May; 11(5):1424-34. PubMed ID: 24588618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety profile of RNAi nanomedicines.
    Barros SA; Gollob JA
    Adv Drug Deliv Rev; 2012 Dec; 64(15):1730-7. PubMed ID: 22732527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicochemical characterization techniques for lipid based delivery systems for siRNA.
    Kapoor M; Burgess DJ; Patil SD
    Int J Pharm; 2012 May; 427(1):35-57. PubMed ID: 21979250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Environment-Responsive Lipid/siRNA Nanoparticles for Cancer Therapy.
    Lu ZR; Laney VEA; Hall R; Ayat N
    Adv Healthc Mater; 2021 Mar; 10(5):e2001294. PubMed ID: 33615743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming the Challenges of siRNA Delivery: Nanoparticle Strategies.
    Shajari N; Mansoori B; Davudian S; Mohammadi A; Baradaran B
    Curr Drug Deliv; 2017; 14(1):36-46. PubMed ID: 27538460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.